IDENTIFICATION OF PATIENT CANDIDATES TO SWITCH FROM TENOFOVIR/EMTRICITABINE TO ABACAVIR/ LAMIVUDINE ANTIRETROVIRAL THERAPY: ECONOMIC SAVING

IDENTIFICATION OF PATIENT CANDIDATES TO SWITCH FROM TENOFOVIR/EMTRICITABINE TO ABACAVIR/ LAMIVUDINE ANTIRETROVIRAL THERAPY: ECONOMIC SAVING